Sabrina S Martinez1, Adriana Campa1, Yinghui Li1, Christina Fleetwood2, Tiffanie Stewart3, Venkataraghavan Ramamoorthy4, Marianna K Baum5. 1. Robert Stempel College of Public Health and Social Work, Florida International University, Miami, FL. 2. Louis A Johnson Veterans Affairs Medical Center, Clarksburg, WV. 3. Center for Nanoscience and Technology, University of Notre Dame, Notre Dame, IN; and. 4. Department of Nutrition and Kinesiology, University of Central Missouri, Warrensburg, MO. 5. Robert Stempel College of Public Health and Social Work, Florida International University, Miami, FL; baumm@fiu.edu.
Abstract
Background: Oxidative stress and reduced antioxidants may be a trigger for liver fibrogenesis. Reducing oxidative stress through higher antioxidant concentration may be a potential antifibrotic target.Objective: We aimed to investigate longitudinally whether plasma zinc, an antioxidant, is related to mitochondrial oxidative stress and the progression of liver fibrosis in the Miami Adult Studies in HIV (MASH) cohort. Methods: A prospective observational cohort study was conducted in 487 predominantly African American HIV-monoinfected and HIV/hepatitis C virus (HCV)-coinfected adults with a mean ± SD age of 47.08 ± 7.67 y from the MASH cohort and followed for a median of 34 mo. Blood was collected for plasma zinc and measures were used to calculate the fibrosis-4 (FIB-4) score (aspartate amino transferase, alanine aminotransferase, and platelets). Plasma zinc deficiency was defined as <0.75 mg/L. Total DNA was extracted from peripheral blood mononuclear cells and mitochondrial DNA (mtDNA) 8-hydroxyguanosine (8-oxo-dG) was determined. Adjusted mixed models were used to assess the relations between zinc, stage of liver disease, and oxidative stress over time and compared between HIV and HIV/HCV groups. Results: Zinc concentrations (β: -0.368, SE = 0.172; P = 0.033) and deficiency were associated with lower FIB-4 scores over time (β: 0.381, SE = 0.118; P = 0.001). Compared with those who were not zinc deficient, zinc-deficient participants had an increased risk of having more-progressed liver disease (OR: 1.91; 95% CI: 1.15, 3.16; P = 0.012). Higher mtDNA 8-oxo-dG was associated with zinc deficiency (β: 0.049, SE = 0.024; P = 0.044) and higher FIB-4 scores over time (β: 0.597, SE = 0.168, P < 0.001).Conclusions: Lower plasma zinc concentrations were associated with liver fibrosis progression and mitochondrial oxidative stress in the HIV and HIV/HCV groups. Zinc may play a role in the impact of liver disease outcomes.
Background: Oxidative stress and reduced antioxidants may be a trigger for liver fibrogenesis. Reducing oxidative stress through higher antioxidant concentration may be a potential antifibrotic target.Objective: We aimed to investigate longitudinally whether plasma zinc, an antioxidant, is related to mitochondrial oxidative stress and the progression of liver fibrosis in the Miami Adult Studies in HIV (MASH) cohort. Methods: A prospective observational cohort study was conducted in 487 predominantly African American HIV-monoinfected and HIV/hepatitis C virus (HCV)-coinfected adults with a mean ± SD age of 47.08 ± 7.67 y from the MASH cohort and followed for a median of 34 mo. Blood was collected for plasma zinc and measures were used to calculate the fibrosis-4 (FIB-4) score (aspartate amino transferase, alanine aminotransferase, and platelets). Plasma zinc deficiency was defined as <0.75 mg/L. Total DNA was extracted from peripheral blood mononuclear cells and mitochondrial DNA (mtDNA) 8-hydroxyguanosine (8-oxo-dG) was determined. Adjusted mixed models were used to assess the relations between zinc, stage of liver disease, and oxidative stress over time and compared between HIV and HIV/HCV groups. Results: Zinc concentrations (β: -0.368, SE = 0.172; P = 0.033) and deficiency were associated with lower FIB-4 scores over time (β: 0.381, SE = 0.118; P = 0.001). Compared with those who were not zinc deficient, zinc-deficientparticipants had an increased risk of having more-progressed liver disease (OR: 1.91; 95% CI: 1.15, 3.16; P = 0.012). Higher mtDNA 8-oxo-dG was associated with zinc deficiency (β: 0.049, SE = 0.024; P = 0.044) and higher FIB-4 scores over time (β: 0.597, SE = 0.168, P < 0.001).Conclusions: Lower plasma zinc concentrations were associated with liver fibrosis progression and mitochondrial oxidative stress in the HIV and HIV/HCV groups. Zinc may play a role in the impact of liver disease outcomes.
Authors: Peter Richardson; Zhigang Duan; Jennifer Kramer; Jessica A Davila; Gia L Tyson; Hashem B El-Serag Journal: Clin Gastroenterol Hepatol Date: 2011-12-07 Impact factor: 11.382
Authors: B Soto; A Sánchez-Quijano; L Rodrigo; J A del Olmo; M García-Bengoechea; J Hernández-Quero; C Rey; M A Abad; M Rodríguez; M Sales Gilabert; F González; P Mirón; A Caruz; F Relimpio; R Torronteras; M Leal; E Lissen Journal: J Hepatol Date: 1997-01 Impact factor: 25.083
Authors: Colette J Smith; Lene Ryom; Rainer Weber; Philippe Morlat; Christian Pradier; Peter Reiss; Justyna D Kowalska; Stephane de Wit; Matthew Law; Wafaa el Sadr; Ole Kirk; Nina Friis-Moller; Antonella d'Arminio Monforte; Andrew N Phillips; Caroline A Sabin; Jens D Lundgren Journal: Lancet Date: 2014-07-19 Impact factor: 79.321
Authors: N C de Souza-Pinto; L Eide; B A Hogue; T Thybo; T Stevnsner; E Seeberg; A Klungland; V A Bohr Journal: Cancer Res Date: 2001-07-15 Impact factor: 12.701
Authors: Vatsalya Vatsalya; Matthew C Cave; Rajarshi Kumar; Shweta Srivastava; Sujita Khanal; Alfred B Jenson; Melanie L Schwandt; Shirish S Barve; Vijay A Ramchandani; Craig J McClain Journal: AIDS Res Hum Retroviruses Date: 2018-12-11 Impact factor: 2.205
Authors: Marianna K Baum; Javier A Tamargo; Richard L Ehman; Kenneth E Sherman; Jun Chen; Qingyun Liu; Raul N Mandler; Colby Teeman; Sabrina S Martinez; Adriana Campa Journal: Drug Alcohol Depend Date: 2021-01-19 Impact factor: 4.492
Authors: Pei-Hui Lin; Matthew Sermersheim; Haichang Li; Peter H U Lee; Steven M Steinberg; Jianjie Ma Journal: Nutrients Date: 2017-12-24 Impact factor: 5.717
Authors: Joshua A Barocas; Kaku So-Armah; Debbie M Cheng; Dmitry Lioznov; Marianna Baum; Kerrin Gallagher; Daniel Fuster; Natalia Gnatienko; Evgeny Krupitsky; Matthew S Freiberg; Jeffrey H Samet Journal: PLoS One Date: 2019-06-27 Impact factor: 3.240
Authors: Min Chul Kim; Jeong In Lee; Jung Hee Kim; Hong Joo Kim; Yong Kyun Cho; Woo Kyu Jeon; Byung Ik Kim; Won Sohn Journal: PLoS One Date: 2020-10-23 Impact factor: 3.240